163 related articles for article (PubMed ID: 38055642)
1. HCC is associated with diabetes and longitudinal blood glucose control in a national cohort with cirrhosis.
Mezzacappa C; Mahmud N; Serper M; John BV; Taddei TH; Kaplan DE
Hepatol Commun; 2023 Dec; 7(12):. PubMed ID: 38055642
[TBL] [Abstract][Full Text] [Related]
2. Diabetes and the risk of cirrhosis and HCC: An analysis of the UK Biobank.
Ye F; Chen L; Zheng X
Hepatol Commun; 2023 Nov; 7(11):. PubMed ID: 37851413
[TBL] [Abstract][Full Text] [Related]
3. Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.
Yang JD; Mohamed HA; Cvinar JL; Gores GJ; Roberts LR; Kim WR
Am J Gastroenterol; 2016 Nov; 111(11):1573-1580. PubMed ID: 27527741
[TBL] [Abstract][Full Text] [Related]
4. Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Nonalcoholic Steatohepatitis-Related, Child-Pugh A Cirrhosis.
Vilar-Gomez E; Calzadilla-Bertot L; Wong VW; Castellanos M; Aller-de la Fuente R; Eslam M; Wong GL; George J; Romero-Gomez M; Adams LA
Clin Gastroenterol Hepatol; 2021 Jan; 19(1):136-145.e6. PubMed ID: 32389886
[TBL] [Abstract][Full Text] [Related]
5. Racial differences in the progression to cirrhosis and hepatocellular carcinoma in HCV-infected veterans.
El-Serag HB; Kramer J; Duan Z; Kanwal F
Am J Gastroenterol; 2014 Sep; 109(9):1427-35. PubMed ID: 25070058
[TBL] [Abstract][Full Text] [Related]
6. Hyperglycemia and chronic liver diseases on risk of hepatocellular carcinoma in Chinese patients with type 2 diabetes--National cohort of Taiwan Diabetes Study.
Li CI; Chen HJ; Lai HC; Liu CS; Lin WY; Li TC; Lin CC
Int J Cancer; 2015 Jun; 136(11):2668-79. PubMed ID: 25387451
[TBL] [Abstract][Full Text] [Related]
7. Increased international normalized ratio level in hepatocellular carcinoma patients with diabetes mellitus.
Zhang H; Gao C; Fang L; Yao SK
World J Gastroenterol; 2013 Apr; 19(15):2395-403. PubMed ID: 23613635
[TBL] [Abstract][Full Text] [Related]
8. Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.
Tsai PC; Kuo HT; Hung CH; Tseng KC; Lai HC; Peng CY; Wang JH; Chen JJ; Lee PL; Chien RN; Yang CC; Lo GH; Kao JH; Liu CJ; Liu CH; Yan SL; Bair MJ; Lin CY; Su WW; Chu CH; Chen CJ; Tung SY; Tai CM; Lin CW; Lo CC; Cheng PN; Chiu YC; Wang CC; Cheng JS; Tsai WL; Lin HC; Huang YH; Yeh ML; Huang CF; Hsieh MH; Huang JF; Dai CY; Chung WL; Chen CY; Yu ML;
J Hepatol; 2023 Feb; 78(2):281-292. PubMed ID: 36208843
[TBL] [Abstract][Full Text] [Related]
9. Diabetes and Cirrhosis Are Risk Factors for Hepatocellular Carcinoma After Successful Treatment of Chronic Hepatitis C.
Hedenstierna M; Nangarhari A; Weiland O; Aleman S
Clin Infect Dis; 2016 Sep; 63(6):723-9. PubMed ID: 27282709
[TBL] [Abstract][Full Text] [Related]
10. Potential role of diabetes mellitus in the progression of cirrhosis to hepatocellular carcinoma: a cross-sectional case-control study from Chinese patients with HBV infection.
Gao C; Fang L; Zhao HC; Li JT; Yao SK
Hepatobiliary Pancreat Dis Int; 2013 Aug; 12(4):385-93. PubMed ID: 23924496
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and outcomes of hepatitis C infection in elderly US Veterans.
El-Serag HB; Kramer J; Duan Z; Kanwal F
J Viral Hepat; 2016 Sep; 23(9):687-96. PubMed ID: 27040447
[TBL] [Abstract][Full Text] [Related]
12. Exposure to Agent Orange and Hepatocellular Carcinoma Among US Military Personnel.
Benhammou JN; Leng M; Shah SC; Cholankeril G; Dong TS; Patel AA; Tong MJ
JAMA Netw Open; 2023 Dec; 6(12):e2346380. PubMed ID: 38048128
[TBL] [Abstract][Full Text] [Related]
13. Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: a nation-wide cohort study.
Huang YW; Wang TC; Yang SS; Lin SY; Fu SC; Hu JT; Liu CJ; Kao JH; Chen DS
Aliment Pharmacol Ther; 2015 Oct; 42(7):902-11. PubMed ID: 26211742
[TBL] [Abstract][Full Text] [Related]
14. Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication.
van der Meer AJ; Feld JJ; Hofer H; Almasio PL; Calvaruso V; Fernández-Rodríguez CM; Aleman S; Ganne-Carrié N; D'Ambrosio R; Pol S; Trapero-Marugan M; Maan R; Moreno-Otero R; Mallet V; Hultcrantz R; Weiland O; Rutter K; Di Marco V; Alonso S; Bruno S; Colombo M; de Knegt RJ; Veldt BJ; Hansen BE; Janssen HLA
J Hepatol; 2017 Mar; 66(3):485-493. PubMed ID: 27780714
[TBL] [Abstract][Full Text] [Related]
15. Risk prediction of hepatocellular carcinoma in patients with cirrhosis: the ADRESS-HCC risk model.
Flemming JA; Yang JD; Vittinghoff E; Kim WR; Terrault NA
Cancer; 2014 Nov; 120(22):3485-93. PubMed ID: 25042049
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal Associations of Risk Factors and Hepatocellular Carcinoma in Patients With Cured Hepatitis C Virus Infection.
Kramer JR; Cao Y; Li L; Smith D; Chhatwal J; El-Serag HB; Kanwal F
Am J Gastroenterol; 2022 Nov; 117(11):1834-1844. PubMed ID: 36327437
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection.
Ioannou GN; Bryson CL; Weiss NS; Miller R; Scott JD; Boyko EJ
Hepatology; 2013 Jan; 57(1):249-57. PubMed ID: 22532055
[TBL] [Abstract][Full Text] [Related]
18. The association between hepatocellular carcinoma and direct-acting anti-viral treatment in patients with decompensated cirrhosis.
Mecci AJ; Kemos P; Leen C; Lawson A; Richardson P; Khakoo SI; Agarwal K; Mutimer D; Rosenberg WM; Foster GR; Irving WL;
Aliment Pharmacol Ther; 2019 Jul; 50(2):204-214. PubMed ID: 31149748
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for HCC in contemporary cohorts of patients with cirrhosis.
Kanwal F; Khaderi S; Singal AG; Marrero JA; Loo N; Asrani SK; Amos CI; Thrift AP; Gu X; Luster M; Al-Sarraj A; Ning J; El-Serag HB
Hepatology; 2023 Mar; 77(3):997-1005. PubMed ID: 35229329
[TBL] [Abstract][Full Text] [Related]
20. Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.
Janjua NZ; Chong M; Kuo M; Woods R; Wong J; Yoshida EM; Sherman M; Butt ZA; Samji H; Cook D; Yu A; Alvarez M; Tyndall M; Krajden M
J Hepatol; 2017 Mar; 66(3):504-513. PubMed ID: 27818234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
